RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.
Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences
MetadataShow full item record
Rubinsztein, D. (2017). RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.. Proc Natl Acad Sci U S A, 114 (41), 10813-10814. https://doi.org/10.1073/pnas.1715241114
Alzheimer’s disease (AD), the leading cause of dementia, is a major cause of death and a significant economic burden. In 2016, ∼700,000 Americans aged 65 and over died of AD, and the total health and social care payments for AD in the United States alone exceeded $230 billion (1). Currently, there are no validated disease-modifying therapies that slow the progression of human AD.
Alzheimer Disease, Inflammation, Peptide Fragments, Amyloid beta-Peptides
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (095317/Z/11/Z)
External DOI: https://doi.org/10.1073/pnas.1715241114
This record's URL: https://www.repository.cam.ac.uk/handle/1810/275412